IL135994A0 - Combination therapy for the treatment of aids - Google Patents
Combination therapy for the treatment of aidsInfo
- Publication number
- IL135994A0 IL135994A0 IL13599498A IL13599498A IL135994A0 IL 135994 A0 IL135994 A0 IL 135994A0 IL 13599498 A IL13599498 A IL 13599498A IL 13599498 A IL13599498 A IL 13599498A IL 135994 A0 IL135994 A0 IL 135994A0
- Authority
- IL
- Israel
- Prior art keywords
- aids
- treatment
- combination therapy
- therapy
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6542197P | 1997-11-13 | 1997-11-13 | |
| GBGB9807938.7A GB9807938D0 (en) | 1998-04-15 | 1998-04-15 | Combination therapy for the treatment of AIDS |
| US9094098P | 1998-06-26 | 1998-06-26 | |
| GBGB9819590.2A GB9819590D0 (en) | 1998-09-08 | 1998-09-08 | Combination therapy for the treatment of aids |
| PCT/US1998/024097 WO1999025352A1 (en) | 1997-11-13 | 1998-11-12 | Combination therapy for the treatment of aids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL135994A0 true IL135994A0 (en) | 2001-05-20 |
Family
ID=27451773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13599498A IL135994A0 (en) | 1997-11-13 | 1998-11-12 | Combination therapy for the treatment of aids |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1044000B1 (de) |
| JP (1) | JP2001522889A (de) |
| KR (1) | KR20010032055A (de) |
| CN (1) | CN1285747A (de) |
| AR (1) | AR013758A1 (de) |
| AT (1) | ATE218866T1 (de) |
| AU (1) | AU749795B2 (de) |
| BG (1) | BG104507A (de) |
| BR (1) | BR9814146A (de) |
| CA (1) | CA2309164A1 (de) |
| CO (1) | CO4970782A1 (de) |
| DE (1) | DE69806062T2 (de) |
| EA (1) | EA200000513A1 (de) |
| ES (1) | ES2177103T3 (de) |
| HU (1) | HUP0100365A3 (de) |
| ID (1) | ID24922A (de) |
| IL (1) | IL135994A0 (de) |
| IS (1) | IS5481A (de) |
| NO (1) | NO20002481L (de) |
| PE (1) | PE20000020A1 (de) |
| PL (1) | PL340430A1 (de) |
| SK (1) | SK6842000A3 (de) |
| TR (1) | TR200001938T2 (de) |
| WO (1) | WO1999025352A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7462733B2 (en) | 2001-07-30 | 2008-12-09 | University Of Southern California | Preparation and use of α-keto phosphonates |
| EP3025718A1 (de) | 2003-01-14 | 2016-06-01 | Gilead Sciences, Inc. | Zusammensetzungen und verfahren für antivirale kombinationstherapie |
| GB2400553A (en) * | 2003-04-14 | 2004-10-20 | Cipla Ltd | Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof |
| TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
| TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ288312B6 (en) * | 1993-12-15 | 2001-05-16 | Merck & Co Inc | HIV-protease inhibitors and pharmaceutical preparations in which they are comprised |
-
1998
- 1998-11-11 CO CO98066470A patent/CO4970782A1/es unknown
- 1998-11-12 HU HU0100365A patent/HUP0100365A3/hu unknown
- 1998-11-12 WO PCT/US1998/024097 patent/WO1999025352A1/en not_active Application Discontinuation
- 1998-11-12 ES ES98959424T patent/ES2177103T3/es not_active Expired - Lifetime
- 1998-11-12 PL PL98340430A patent/PL340430A1/xx unknown
- 1998-11-12 ID IDW20000895A patent/ID24922A/id unknown
- 1998-11-12 AR ARP980105720A patent/AR013758A1/es unknown
- 1998-11-12 AU AU15225/99A patent/AU749795B2/en not_active Ceased
- 1998-11-12 CN CN98813077A patent/CN1285747A/zh active Pending
- 1998-11-12 BR BR9814146-5A patent/BR9814146A/pt not_active Application Discontinuation
- 1998-11-12 EP EP98959424A patent/EP1044000B1/de not_active Expired - Lifetime
- 1998-11-12 CA CA002309164A patent/CA2309164A1/en not_active Abandoned
- 1998-11-12 TR TR2000/01938T patent/TR200001938T2/xx unknown
- 1998-11-12 KR KR1020007005176A patent/KR20010032055A/ko not_active Application Discontinuation
- 1998-11-12 PE PE1998001094A patent/PE20000020A1/es not_active Application Discontinuation
- 1998-11-12 IL IL13599498A patent/IL135994A0/xx unknown
- 1998-11-12 AT AT98959424T patent/ATE218866T1/de not_active IP Right Cessation
- 1998-11-12 EA EA200000513A patent/EA200000513A1/ru unknown
- 1998-11-12 DE DE69806062T patent/DE69806062T2/de not_active Expired - Fee Related
- 1998-11-12 JP JP2000520785A patent/JP2001522889A/ja not_active Withdrawn
- 1998-11-12 SK SK684-2000A patent/SK6842000A3/sk unknown
-
2000
- 2000-05-09 IS IS5481A patent/IS5481A/is unknown
- 2000-05-12 NO NO20002481A patent/NO20002481L/no not_active Application Discontinuation
- 2000-06-05 BG BG104507A patent/BG104507A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL340430A1 (en) | 2001-02-12 |
| AR013758A1 (es) | 2001-01-10 |
| PE20000020A1 (es) | 2000-01-27 |
| IS5481A (is) | 2000-05-09 |
| CA2309164A1 (en) | 1999-05-27 |
| JP2001522889A (ja) | 2001-11-20 |
| HUP0100365A2 (hu) | 2002-05-29 |
| EA200000513A1 (ru) | 2000-10-30 |
| ES2177103T3 (es) | 2002-12-01 |
| NO20002481L (no) | 2000-07-12 |
| DE69806062D1 (de) | 2002-07-18 |
| KR20010032055A (ko) | 2001-04-16 |
| DE69806062T2 (de) | 2003-03-20 |
| AU1522599A (en) | 1999-06-07 |
| ATE218866T1 (de) | 2002-06-15 |
| BG104507A (bg) | 2001-03-30 |
| TR200001938T2 (tr) | 2001-07-23 |
| HUP0100365A3 (en) | 2002-06-28 |
| SK6842000A3 (en) | 2000-12-11 |
| CO4970782A1 (es) | 2000-11-07 |
| AU749795B2 (en) | 2002-07-04 |
| ID24922A (id) | 2000-08-31 |
| EP1044000B1 (de) | 2002-06-12 |
| WO1999025352A1 (en) | 1999-05-27 |
| CN1285747A (zh) | 2001-02-28 |
| EP1044000A1 (de) | 2000-10-18 |
| NO20002481D0 (no) | 2000-05-12 |
| BR9814146A (pt) | 2000-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP980222B1 (en) | Pyrazolopyrimidinones for the treatment of sexual disfunction | |
| EP1077704A4 (de) | Kombinationstherapie zur behandlung der depression | |
| EP1063990A4 (de) | Therapie von estrogenabhängigen erkrankungen | |
| GB9824436D0 (en) | Methods of treatment | |
| AP9801414A0 (en) | Combination effective for the treatment of impotence | |
| IL142588A0 (en) | Therapy for improving cognition | |
| EP0959879A4 (de) | Photodynamische therapie zur behandlung von osteosrthritis | |
| GB9808936D0 (en) | Combination therapy for the prevention and treatment of osteoporosis | |
| PL336579A1 (en) | Treatment of diseases associated with cytokinins | |
| AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
| GB9725114D0 (en) | Treatment of pruritus | |
| IL135994A0 (en) | Combination therapy for the treatment of aids | |
| GB0020261D0 (en) | Therapeutic treatment | |
| ZA9810306B (en) | Combination therapy for the treatment of aids | |
| GB9819590D0 (en) | Combination therapy for the treatment of aids | |
| GB9807938D0 (en) | Combination therapy for the treatment of AIDS | |
| HUP0103568A3 (en) | Treatment of depression | |
| ZA982994B (en) | Therapeutic treatment | |
| GB9721978D0 (en) | Treatment of depression | |
| GB9726745D0 (en) | Treatment of medical conditions | |
| GB9701448D0 (en) | Methods of treatment | |
| SI1068199T1 (en) | N-aryloxyethyl-indoly-alkylamines for the treatment of depression | |
| GB9710544D0 (en) | Medical treatment | |
| GB9710054D0 (en) | Treatment of diseases | |
| GB9716630D0 (en) | Treatment of propolis |